Showing results (251-260 of 265) with videos related to
Sort By:
Pageof 27
BMC Cancer|April 6, 2017
The efficacy and safety of CapeOX plus bevacizumab therapy followed by capecitabine plus bevacizumab maintenance therapy in patients with metastatic colorectal cancer: a multi-center, single-arm, phase II study (CCOG-0902)Goro Nakayama, Kiyoshi Ishigure, Hiroyuki Yokoyama, et al.Trials|April 29, 2019
A double-blind randomized comparative clinical trial to evaluate the safety and efficacy of dendritic cell vaccine loaded with WT1 peptides (TLP0-001) in combination with S-1 in patients with advanced pancreatic cancer refractory to standard chemotherapyMasahiro Katsuda, Motoki Miyazawa, Toshiyasu Ojima, et al.International Journal of Cancer|August 27, 2014
Combination therapy of oncolytic herpes simplex virus HF10 and bevacizumab against experimental model of human breast carcinoma xenograftGewen Tan, Hideki Kasuya, Tevfik Tolga Sahin, et al.Nagoya Journal of Medical Science|June 27, 2019
Phase II study of chemoradiotherapy combined with gemcitabine plus nab-paclitaxel for unresectable locally advanced pancreatic ductal adenocarcinoma (NUPAT 05 Trial): study protocol for a single arm phase II studyNao Takano, Suguru Yamada, Akihiro Hirakawa, et al.The Oncologist|July 28, 2018
Randomized Phase II Trial of CapOX plus Bevacizumab and CapIRI plus Bevacizumab as First-Line Treatment for Japanese Patients with Metastatic Colorectal Cancer (CCOG-1201 Study)Goro Nakayama, Ayako Mitsuma, Yuki Sunagawa, et al.Hepatology (Baltimore, Md.)|March 29, 2014
Epidermal growth factor receptor inhibition attenuates liver fibrosis and development of hepatocellular carcinomaBryan C Fuchs, Yujin Hoshida, Tsutomu Fujii, et al.Hepato-Gastroenterology|July 16, 2015
Phase I Dose-escalation Clinical Trial of HF10 Oncolytic Herpes Virus in 17 Japanese Patients with Advanced CancerHideki Kasuya, Yasuhiro Kodera, Akimasa Nakao, et al.Trials|September 17, 2021
ISOlation Procedure vs. conventional procedure during Distal Pancreatectomy (ISOP-DP trial): study protocol for a randomized controlled trialKen-Ichi Okada, Manabu Kawai, Seiko Hirono, et al.Journal of Gastroenterology|October 19, 2022
Clinical practice guidelines for duodenal cancer 2021Kenji Nakagawa, Masayuki Sho, Mitsuhiro Fujishiro, et al.European Journal of Cancer (Oxford, England : 1990)|December 19, 2020
Randomised phase II trial of capecitabine plus oxaliplatin with continuous versus intermittent use of oxaliplatin as adjuvant chemotherapy for stage II/III colon cancer (CCOG-1302 study)Goro Nakayama, Nao Takano, Hiroya Taniguchi, et al.Pageof 27